| Literature DB >> 18466353 |
J Ahenkorah1, B Hottor, S Byrne, P Bosio, C D Ockleford.
Abstract
We show here that at least 5 keratin proteins are present in villous trophoblast and the same 5 in extravillous trophoblast. A further 14 tested were undetectable in these tissues. In contrast, 10 of the 19 keratins tested were present in amniotic epithelium. The marking of amniotic epithelium on the one hand, as distinct from villous and extravillous trophoblast on the other, can be achieved using 5 keratins (K4, 6, 13, 14 and 17) with a mixture of positive and negative discrimination that is expected, in combination, to be highly sensitive. All the specific keratins identified in trophoblast were apparently up-regulated on the pathway to extravillous trophoblast. Co-ordinated differentiation at the molecular expression level is indicated by this finding. The relevant keratins are K5, 7, 8, 18 and 19. Specific keratins have been identified that are down-regulated in villous trophoblast in pre-eclamptic pregnancy. This difference between healthy and pre-eclamptic chorionic villous trophoblast keratin expression was statistically significant in 4 out of the 5 keratins. This was not the case for the extravillous trophoblast at the immunofluorescence confocal level but significant differences were obtained using immunogold electron microscopy. We suggest that the villous trophoblast in pre-eclamptic placentae is cytoskeletally weaker with respect to the filaments made from these specific proteins and that this is one reason why, in pre-eclampsia, trophoblast is deported in greater quantity than in healthy placentae.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18466353 PMCID: PMC3822880 DOI: 10.1111/j.1582-4934.2008.00363.x
Source DB: PubMed Journal: J Cell Mol Med ISSN: 1582-1838 Impact factor: 5.310
Properties of the antibodies used for immunocytochemical and immuno-electron microscopic localisation of keratins described in the text.
| Anti-keratin | Source | Clone | Primary dilution | Secondary dilution | Isotype |
|---|---|---|---|---|---|
| K1 | Santa Cruz Biotechnology, Inc. | LHK1,# sc-53249 | 1:50 | 1:100 | lgG2a |
| K2 | Santa Cruz Biotechnology, Inc. | AE3,# sc-57004 | 1:20 | 1:100 | IgG1 |
| K3 | Santa Cruz Biotechnology, Inc. | Q-14,# sc-49181 | 1:50 | 1: 100 | IgG |
| K4 | Sigma-Aldrich | 6B10,# C5176 | 1: 20 | 1:50 | IgG1 |
| K5 | Santa Cruz Biotechnology, Inc. | RCK103,# sc-32721 | 1: 50 | 1:100 | IgG1 |
| K6 | Serotec | LHK6B, MCA 1869 | 1: 20 | 1: 50 | lgG2a |
| K7 | Sigma-Aldrich | LDS-68,#C6417 | 1: 150 | 1: 50 | IgG1 |
| K8 | Sigma-Aldrich | M20,#C5301 | 1: 400 | 1: 50 | IgG1 |
| K9 | American Research products, Inc.™ | Ks 9.70 & Ks 9.216 | 1: 20 | 1: 100 | IgGi+ lgG3 |
| K10 | Serotec | MCA 1871T, #070905 | 1: 40 | 1: 50 | IgGi |
| K12 | Santa Cruz Biotechnology, Inc. | L-20,sc-17099 | 1: 50 | 1: 100 | IgG |
| K13 | Sigma-Aldrich | KS-1A3,#C0791 | 1: 20 | 1: 50 | IgG1 |
| K14 | Sigma-Aldrich | CKB1,#C8791 | 1: 50 | 1: 50 | IgM |
| K15 | Santa Cruz Biotechnology, Inc. | LHK15, sc-47697 | 1: 50 | 1: 100 | IgG |
| K16 | Santa Cruz Biotechnology, Inc. | LL025, sc-53255 | 1: 50 | 1: 100 | IgG |
| K17 | Sigma-Aldrich | CK-E3,#C9179 | 1: 50 | 1: 50 | lgG2b |
| K18 | Sigma-Aldrich | CY-90,#F4772 | 1: 1000 | 1: 60 | lgG1 |
| K19 | Sigma-Aldrich | A53-B/A2 | 1: 50 | 1: 60 | lgG2a |
| K20 | Santa Cruz Biotechnology, Inc. | Q2,#8c-58730 | 1: 20 | 1: 100 | lgG1 |
Suppliers details are as follows Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA; Sigma-Aldrich, St. Louis, MO USA; AbD Serotec, MorphoSys UK Ltd., Kidlington, Oxford, UK; American Research Products, Inc(tm) ARP, Belmont, MA, USA.
4Boxplot showing interquartile range of the CLSM immunofluorescence data using the anti-keratin-7 antibody on pre-eclamptic chorionic villous trophoblast (CVTp) and extravillous trophoblast (EVTp), also healthy chorionic villous trophoblast (CVTh) and extravillous trophoblast (EVTh). The minimum, median and maximum values are indicated by the key and the whisker shows the range.
1(A) Keratin 7 distribution over the villous tree (lower left) separated by the basal plate (bp) from extravillous trophoblast (evts: upper right). The immunofluorescence intensity is positive over the villous epithelium and the extravillous trophoblast cells, but much more intense over the latter. Scale bar = 250 μm. (B) Isotype control with mouse IgG1 same dilution of 1:150 as anti-K7 antibody. Scale bar = 250 μm. (C) Anti-keratin 17 immunofluorescence distribution over the amniochorion. The immunofluorescence is intense over the amniotic epithelium cytoplasm. Note that the compact, fibroblast, spongy and reticular layers and the chorion leave trophoblast cells are unlabelled. Scale bar = 25 μm. Inset: Anti-keratin 17 distribution over a region containing villous and extravillous trophoblast. The immunofluorescence intensity is below the background level of detection. Scale bar = 100 μm. (D) Anti-keratin 7 immunofluorescence of amniochorion. Note that the amniotic epithelium (single arrow) is scarcely above background levels whilst the EVTs in the chorion (double arrows) are highly immunoreactive. Scale bar = 250 μm. (E) Immunofluorescence of anti-keratin 7 showing a cluster of brightly immunofluorescent EVTs and linear stretch of EVTs (lower right) in the basal plate tissue. As usual the chorionic villi are less immunoreactive. Scale bar = 250 μm. (F) Anti-keratin 13 immunofluorescence of amniochorion. Scale bar = 100 μm. (G) Anti-keratin 14 immunofluorescence of amniotic epithelium. Scale bar = 25 μm. Inset: Basal plate tissue showing no immunofluorescence above background. Scale bar = 100 μm. (H) Anti-keratin 5 immunofluorescence of basal plate tissue. It is of low intensity on the lower part (CVTs) and brighter on the upper part (EVTs). Scale bar = 250 μm.
2(A & B) The graph on the right shows the pixel intensity distribution over areas of chorionic villous trophoblast (pink line) and extravillous trophoblast (blue line) when indirect immunofluorescence preparations of keratin 18 are imaged. The areas sampled for the intensity distribution graphs are shown on the left and the pixels of highest greyscale value (210–255) equivalent to immuno-fluorescence intensity have been banded red. The red banding corresponds to the location of EVT and is only infrequently seen in chorionic villous trophoblast.
3(A & B) This is an indirect immuno-fluorescence preparation using anti-keratin 7. The areas sampled for the intensity distribution graphs are shown on the left and the pixels of highest grey scale value (210–255) equivalent to immunofluorescence intensity have been banded red. The red banding corresponds to the location of EVT and is only infrequently seen in chorionic villous trophoblast. The graph on the right shows the pixel intensity distribution of high greyscale pixels within this brightness band over areas of chorionic villous trophoblast (pink line) and extravillous trophoblast (blue line).
Overview of keratins expression
| Keratins (K) | CVT | EVT | Amniotic epithelium |
|---|---|---|---|
| 1 | - | - | - |
| 2 | - | - | - |
| 3 | - | - | - |
| 4 | - | - | + |
| 5 | + | ++ | + |
| 6 | - | - | + |
| 7 | + | ++ | - |
| 8 | + | ++ | + |
| 9 | - | - | - |
| 10 | - | - | + |
| 12 | - | - | - |
| 13 | - | - | + |
| 14 | - | - | + |
| 15 | - | - | - |
| 16 | - | - | - |
| 17 | - | - | + |
| 18 | + | ++ | + |
| 19 | + | ++ | + |
| 20 | - | - | - |
The table shows the distribution of 19 distinct molecular forms of keratin (K) in human term extra-embryonic membrane ectoderm including the amniotic epithelium, chorionic villous trophoblast (CVT) and extravillous trophoblast (EVT).
Expression is defined as follows:
(-) = not expressed above background.
(+) = expressed.
(++) = up-regulated.
8(A) Transmission electron micrograph of intermediate filament bundles associated with anti-K18 coated 10-nm colloidal gold particles. Gold particles (black arrows) are seen over the filament bundle (white arrow) but not the surrounding cytoplasm. (B) In this transmission electron micrograph of chorionic villous trophoblast relatively few keratin fibres are seen and there are correspondingly less anti-K18 conjugated gold particles (arrow). Note that areas such as the nucleus (n), microvilli (mv) and intervillous space (ivs) are entirely unlabelled with gold particles. (C) Keratin filaments without gold particles are observed in this negative control section of extravillous trophoblast exposed to colloidal gold in the absence of first step antibody to keratin 18. (D) Intermediate filaments associated with anti keratin 7 conjugated 10-nm colloidal gold particles (arrow) became detectable only after epitope unmasking. Note that the nucleus and non-intermediate filament containing cytoplasm are unlabelled.
Descriptive statistics of K7 immunogold labelling
| Observations | Mean | Std. Err | Std. Dev. | 95% | CI | |
|---|---|---|---|---|---|---|
| CVTh | 23 | 1.578 | 0.1562 | 0.7490 | 1.2542 | 1.9019 |
| CVTp | 14 | 0.926 | 0.0748 | 0.2800 | 0.7643 | 1.0877 |
| EVTh | 30 | 3.700 | 0.2341 | 1.2820 | 3.2213 | 4.1787 |
| EVTp | 21 | 1.545 | 0.29852 | 1.3680 | 1.92469 | 2.1677 |
Independent two sample t-test comparing CVTh and CVTp (t= 3.7649, P< 0.0007).
Comparing EVTh and EVTp (t= 5.6809, P< 0.0001).
Descriptive statistics of K18 immunogold labelling
| Observations | Mean | Std. Err | Std. Dev. | 95% | CI | |
|---|---|---|---|---|---|---|
| CVTh | 11 | 2.289 | 0.3488 | 1.1570 | 1.5117 | 3.0663 |
| CVTp | 14 | 0.912 | 0.1024 | 0.3830 | 0.6909 | 1.1331 |
| EVTh | 14 | 6.301 | 0.8504 | 3.1820 | 4.4638 | 8.1382 |
| EVTp | 19 | 2.505 | 0.2762 | 1.2040 | 1.9247 | 3.0853 |
Independent two sample t-test comparing CVTh and CVTp (t= 3.7876, P < 0.0026).
Comparing EVTh and EVTp (t= 4.2453, P < 0.0006).
K7 statistics
| Tissue | Min | Max | % Median pixel value | 25th percentile | 75th percentile | |
|---|---|---|---|---|---|---|
| CVTp | 95 | 0.00 | 4.10 | 0.04 | 0.00 | 0.18 |
| EVTp | 95 | 0.03 | 15.94 | 2.93 | 1.36 | 6.08 |
| CVTh | 95 | 0.00 | 5.60 | 0.17 | 0.02 | 0.75 |
| EVTh | 95 | 0.01 | 17.97 | 4.06 | 1.76 | 7.07 |
The table shows the results of statistical analysis of the keratin 7 (K7) immunofluorescence intensity data in pre-eclamptic chorionic villous
trophoblast (CVTp) pre-eclamptic extravillous trophoblast (EVTp) and their healthy control tissues (CVTh and EVTh). The statistically significant
level was set at P less than 0.05 for data in tables 2–5: outcomes were assigned as follows:-
Wilcoxon sign-rank test:
Comparing CVTp and EVTp [Z =−8.463, P = 0.0001]***
Comparing CVTh and EVTh [Z =−8.248, P = 0.0001]***
Two sample Wilcoxon rank-sum (Mann-Whitney) Test:
Comparing CVTp and CVTh [Z =−3.262, P = 0.0011]***
Comparing EVTp and EVTh [Z =−1.509, P = 0.1312] ns
6Boxplot showing interquartile range of the CLSM immunofluorescence data using the anti-keratin-18 antibody on pre-eclamptic chorionic villous trophoblast (CVTp) and extravillous trophoblast (EVTp) and healthy chorionic villous trophoblast (CVTh) and extravil-lous trophoblast (EVTh). The minimum median and maximum values are indicated by the key and the whisker shows the range.
K18 statistics
| Tissue | Min | Max | % Median pixel value | 25th percentile | 75th percentile | |
|---|---|---|---|---|---|---|
| CVTp | 85 | 0.00 | 2.44 | 0.08 | 0.01 | 0.23 |
| EVTp | 85 | 0.00 | 11.66 | 2.11 | 1.00 | 4.12 |
| CVTh | 85 | 0.00 | 7.18 | 0.50 | 0.18 | 1.05 |
| EVTh | 85 | 0.11 | 14.66 | 2.90 | 1.54 | 4.70 |
The table shows the results of statistical analysis of the keratin 18 (K18) immunofluorescence intensity data in pre-eclamptic chorionic villous
trophoblast (CVTp) pre-eclamptic extravillous trophoblast (EVTp) and their healthy control tissues (CVTh and EVTh). Significance was assigned as
follows:-
Wilcoxon sign-rank test:
Comparing CVTp and EVTp [Z =−7.905, P = 0.0001]***
Comparing CVTh and EVTh [Z =−7.328, P = 0.0001]***
Two sample Wilcoxon rank-sum (Mann-Whitney) Test:
Comparing CVTp and CVTh [Z =−6.117, P = 0.0001]***
Comparing EVTp and EVTh [Z =−1.789, P = 0.0736] ns
K8 statistics
| Tissue | Min | Max | % Median pixel value | 25th percentile | 75th percentile | |
|---|---|---|---|---|---|---|
| CVTp | 89 | 0.00 | 7.22 | 0.03 | 0.00 | 0.20 |
| EVTp | 89 | 0.60 | 11.40 | 1.86 | 1.13 | 3.55 |
| CVTh | 89 | 0.00 | 8.96 | 0.32 | 0.03 | 0.88 |
| EVTh | 89 | 0.17 | 13.75 | 2.88 | 1.00 | 4.86 |
The table shows the results of statistical analysis of the keratin 8 (K8) immunofluorescence intensity data in pre-eclamptic chorionic villous trophoblast (CVTp) pre-eclamptic extravillous trophoblast (EVTp) and their healthy control tissues (CVTh and EVTh). Significance was assigned as follows:-
Wilcoxon sign-rank test:
Comparing CVTp and EVTp [Z =−7.974, P = 0.0001]***
Comparing CVTh and EVTh [Z =−7.624, P = 0.0001]***
Two sample Wilcoxon rank-sum (Mann-Whitney) Test: Comparing CVTp and CVTh [Z =−3.342, P = 0.0008]***
Comparing EVTp and EVTh [Z =−1.751, P = 0.0799] ns
K19 statistics
| Tissue | Min | Max | % Median pixel value | 25th percentile | 75th percentile | |
|---|---|---|---|---|---|---|
| CVTp | 83 | 0 | 1.97 | 0.01 | 0.00 | 0.06 |
| EVTp | 83 | 0 | 9.26 | 0.62 | 0.21 | 1.77 |
| CVTh | 83 | 0 | 1.38 | 0.04 | 0.00 | 0.10 |
| EVTh | 83 | 0 | 9.50 | 1.06 | 0.42 | 2.45 |
The table shows the results of statistical analysis of the keratin 19 (K19) immunofluorescence intensity data in pre-eclamptic chorionic villous trophoblast
(CVTp) pre-eclamptic extravillous trophoblast (EVTp) and their healthy control tissues (CVTh and EVTh). Significance was assigned as follows:-
Wilcoxon sign-rank test:
Comparing CVTp and EVTp [Z =−7.478, P = 0.0001]*** up-regulated
Comparing CVTh and EVTh [Z =−7.693, P = 0.0001]***
Two sample Wilcoxon rank-sum (Mann-Whitney) test:
Comparing CVTp and CVTh [Z =−1.941, P = 0.0522]* threshold
Comparing EVTp and EVTh [Z =−1.867, P = 0.0619] ns